This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies
By closing this message or continuing to use our site, you agree to our cookie policy. Learn More
This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Cannabis products logo
search
cart
facebook twitter linkedin youtube
Cannabis products logo
  • Home
  • News
    • Cannabis Industry News
    • Cannabis Coronavirus Coverage
  • Products
  • Business
    • Entering the Market
    • Industry Trends
    • Market Research
    • Demographics
  • Law
    • Regulatory
  • Ingredients
    • Cannabinoids
    • Terpenes
    • Hemp
    • Flavors
  • Equipment
    • Edibles Processing
    • Beverages Processing
    • Packaging Equipment
    • Analytical & QA/QC
  • Packaging
    • Packaging Safety
    • Shelf Life
    • Branding
  • Categories
    • Beverages
    • Candy
    • Foodservice
    • Prepared Foods
    • Bakery
    • Snacks
  • More
    • Digital Editions
    • Podcasts
    • eNewsletter
    • Store
    • Connect
    • Contact Us
    • Advertise
  • Partners
    • Prepared Foods
    • Food Engineering
    • Food Master
    • Food Safety Strategies
  • CPX
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA Issues Warning Letter Against Curaleaf for Making Unapproved Claims on CBD Products

You have 0 Articles Left This Month. Register Today for Unlimited Access.

Cannabis ProductsCannabis Industry NewsCannabis LawCannabis Regulatory

FDA Issues Warning Letter Against Curaleaf for Making Unapproved Claims on CBD Products

Federal agency says Curaleaf claimed CBD could treat cancer, Alzheimer’s, among other conditions.

July 29, 2019
Alyse Thompson
KEYWORDS cannabidiol (CBD) / cannabis foods and beverages / cannabis regulation / FDA
Order Reprints
No Comments

The US Food and Drug Administration issued on July 23 a warning letter to Curaleaf Inc. for selling products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease and opioid withdrawal, among other conditions or diseases.

“As we examine potential regulatory pathways for the lawful marketing of products containing cannabis and cannabis-derived compounds like CBD, protecting and promoting public health remains our top priority,” said FDA Acting Commissioner Ned Sharpless in a news release. “Selling unapproved products with unsubstantiated therapeutic claims — such as claims that CBD products can treat serious diseases and conditions — can put patients and consumers at risk by leading them to put off important medical care.”

You have 0 complimentary articles left.

Register for free today to continue reading!

Already have an account? Sign in here.

Privacy Policy

Related Articles

Legal perspectives on the state of CBD

Legal status of CBD poses challenges for product developers, ingredient suppliers

Former Chipotle execs enter CBD industry with new extraction company

Curaleaf Acquires Colorado Edibles Maker BlueKudu

Related Events

5 Things to Know When Creating a CBD Beverage

Subscribe to Food Engineering
Subscribe to Food Safety Strategies
 
Connect with Cannabis Products

The latest news and information

Content Focused on Food & Beverage Product Development

SUBSCRIBE TODAY
  • More
    • Want More
    • Connect
    • Editorial Guidelines
    • New Product Submission Form
    • Food & Beverage Brands
    • Custom Content & Marketing Services
    • Market Research
    • List Rental
    • Survey And Sample
  • Advertise With Us
    • Advertise
  • Subscribe
  • PRIVACY
    • PRIVACY POLICY
    • TERMS & CONDITIONS
    • DO NOT SELL MY PERSONAL INFORMATION
    • PRIVACY REQUEST
    • ACCESSIBILITY

Copyright ©2021. All Rights Reserved BNP Media.

Design, CMS, Hosting & Web Development :: ePublishing